First-in-Human trial tests pill to fight diabetic vision loss
NCT ID NCT04187443
Summary
This early-stage study is testing the safety and initial effects of an oral medication called MS-553 for people with diabetic macular edema, a swelling in the eye that can cause vision loss. Forty-five participants who have not yet received treatment for this condition will take the pill for eight weeks. Researchers will monitor for side effects and check if the drug reduces swelling in the retina and improves vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, 200080, China
Contact
Contact
-
The Second Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.